Study period | ||||||
---|---|---|---|---|---|---|
Enrollment | Post-allocation | Follow-up | ||||
Timepoint | Ambulance | During primary PCI | Following Primary PCI | During admission at Rigshospitalet | Days 90 | |
Enrolment: | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
Randomization | X | |||||
Interventions: | ||||||
Infusion of study medicine | X | |||||
Assessments: | ||||||
CMR | X | X | ||||
Infarct sizea | X | X | ||||
Extent of MVOa | X | X | ||||
IMHa | X | |||||
AARa | X | |||||
MSIa | X | X | ||||
LVEFa | X | X | ||||
Mortality and hospitalization for heart failure | X | |||||
Biochemistry and biobank samples | X | X | X | |||
Coronary physiology | X |